DrugPatentWatch Database Preview

Details for Patent: 7,700,081

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 7,700,081 protect, and when does it expire?

Patent 7,700,081 protects CLOBEX and is included in one NDA.

This patent has thirty-two patent family members in twenty-one countries.

Summary for Patent: 7,700,081

Title:	Foaming compositions for hair care
Abstract:	The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterised in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
Inventor(s):	Preuilh; Isabelle (Le Cannet, FR), Guise; Anne-Emmanuelle (Rouen, FR), Willcox; Nathalie (Le Rouret, FR)
Assignee:	Galderma S.A. (Cham, CH)
Application Number:	11/453,936
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 7,700,081

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Galderma Labs	CLOBEX	clobetasol propionate	SHAMPOO;TOPICAL	021644-001	Feb 5, 2004	AB	RX	Yes	Yes						TOPICAL TREATMENT OF SCALP PSORIASIS

Foreign Priority and PCT Information for Patent: 7,700,081

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
France	98 07802	Jun 19, 1998

International Family Members for US Patent 7,700,081

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	019321
Austria	308960
Austria	444054
Australia	4151499